Internal Medicine, Hematology · Honolulu, HI
NPI
1477663284
Since 2006
Specialty
Internal Medicine, Hematology
Code 207RH0000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
1329 Lusitana St Ste 307
Honolulu, HI, 96813
Phone (808) 524-6115
Groups this clinician bills Medicare through
Medicare paid, 2024
$948K
42,470 services
Medicare patients, 2024
336
Average age 77
Drug cost, 2024
$7.8M
1,246 prescriptions
Company payments, 2025
$5,320
From 51 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jon Fukumoto was code J0885 (injection, epoetin alfa, (for non-esrd use), 1000 units), 3,669 times for 18 patients. In total Jon Fukumoto billed 42,470 services in 117 codes, and Medicare paid $948K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-07-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 3,669 | 18 | $6.12 | $22K |
| 85025 Blood Count | Office | 858 | 269 | $7.55 | $6,478 |
| 36415 Venipuncture Blood Collection | Office | 825 | 266 | $7.13 | $5,886 |
| 99213 Office E&M - Established | Office | 514 | 203 | $65.05 | $33K |
| 99214 Office E&M - Established | Office | 258 | 93 | $106.51 | $27K |
| 80053 Clinical Chemistry | Office | 217 | 77 | $10.27 | $2,229 |
| 96372 Injection Administration | Office | 211 | 38 | $11.74 | $2,477 |
| 80048 Clinical Chemistry | Office | 153 | 78 | $8.18 | $1,252 |
| 82728 Clinical Chemistry | Office | 137 | 70 | $13.36 | $1,830 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 130 | 11 | $0.09 | $11.59 |
| 80076 Clinical Chemistry | Office | 112 | 43 | $7.94 | $889 |
| 99195 Treatment - Miscellaneous | Office | 95 | 31 | $73.22 | $6,956 |
| 96365 Intravenous Infusion, Hydration | Office | 48 | 16 | $53.21 | $2,554 |
| 96367 Intravenous Infusion, Hydration | Office | 42 | 14 | $21.28 | $894 |
| 96413 Chemotherapy Administration | Office | 39 | 16 | $109.03 | $4,252 |
By year: 2022 $715K for 46,568 services; 2023 $174K for 14,754 services; 2024 $948K for 42,470 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 858 | 269 | $7.55 | $6,478 |
| 36415 Venipuncture Blood Collection | 825 | 266 | $7.13 | $5,886 |
| 80053 Clinical Chemistry | 217 | 77 | $10.27 | $2,229 |
| 80048 Clinical Chemistry | 153 | 78 | $8.18 | $1,252 |
| 82728 Clinical Chemistry | 137 | 70 | $13.36 | $1,830 |
| 80076 Clinical Chemistry | 112 | 43 | $7.94 | $889 |
| 83615 Clinical Chemistry | 34 | 23 | $5.92 | $201 |
| 84443 Clinical Chemistry | 13 | 13 | $16.46 | $214 |
Medicare prescription drug claims, 2024
In 2024, the drug Jon Fukumoto prescribed most often to Medicare patients was Hydroxyurea, with 89 prescriptions and refills. In total Jon Fukumoto wrote 1,246 Medicare prescriptions that cost $7.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxyurea Generic | 89 | 245 | 27 | $3,546 |
| Imbruvica Ibrutinib | 72 | 87 | Under 11 | $1.2M |
| Procrit Epoetin Alfa | 72 | 77 | 16 | $95K |
| Dexamethasone Generic | 55 | 124 | 21 | $845 |
| Lenalidomide Generic | 52 | 52 | Under 11 | $979K |
| Bosulif Bosutinib | 50 | 50 | Under 11 | $581K |
| Kyprolis Carfilzomib | 39 | 39 | Under 11 | $273K |
| Deferasirox Generic | 37 | 38 | Under 11 | $176K |
| Methotrexate Methotrexate Sodium | 33 | 59 | Under 11 | $589 |
| Darzalex Faspro Daratumumab-Hyaluronidase-Fihj | 29 | 29 | Under 11 | $390K |
| Prednisone Generic | 29 | 45 | 12 | $154 |
| Inqovi Decitabine/Cedazuridine | 29 | 48 | Under 11 | $244K |
| Cyclosporine Generic | 27 | 35 | Under 11 | $12K |
| Levofloxacin Generic | 26 | 27 | 15 | $391 |
| Potassium Chloride Generic | 24 | 38 | Under 11 | $208 |
Brand drugs: 558 claims; generic drugs: 688 claims; opioid claims: 34.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jon Fukumoto $5,320 ($5,320 in general payments such as food, travel and fees) from 51 companies. The largest payer was Janssen Biotech, Inc. with $526.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 15 | $526 |
| Incyte Corporation INCY | 14 | $400 |
| Pfizer Inc. PFE | 12 | $375 |
| Abbvie Inc. ABBV | 13 | $359 |
| Genzyme Corporation SNY | 8 | $320 |
| Syndax Pharmaceuticals, Inc. SNDX | 3 | $267 |
| Sanofi US Services Inc. SNY | 2 | $257 |
| PharmaEssentia USA Corporation 6446.TW | 10 | $252 |
| Karyopharm Therapeutics Inc. KPTI | 4 | $167 |
| Daiichi Sankyo Inc. 4568.T | 6 | $151 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.